DiaMedica Therapeutics (DMAC) Accumulated Depreciation (2017 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Accumulated Depreciation came in at $159000.0 in Q1 2026, up 30.33% year-on-year from $122000.0 in Q1 2025, and up 6.0% quarter-over-quarter from $150000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Accumulated Depreciation (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics' Accumulated Depreciation history runs 10 years deep, the most recent figure standing at $159000.0 for Q1 2026.
- On a quarterly basis, Accumulated Depreciation rose 30.33% year-over-year to $159000.0 in Q1 2026; TTM through Mar 2026 was $159000.0, a 30.33% increase from a year earlier, with the FY2025 full-year figure at $150000.0, up 31.58% from the prior year.
- Accumulated Depreciation grew to $159000.0 in Q1 2026 per DMAC's latest filing, from $150000.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $159000.0 in Q1 2026 and bottomed at $62000.0 in Q1 2022.
- The 5-year median for Accumulated Depreciation is $100000.0 (2023), against an average of $104117.6.
- Across the five-year window, Accumulated Depreciation rose 6.19% in 2024 and soared 34.95% in 2025, its largest moves.
- Year by year, Accumulated Depreciation stood at $80000.0 in 2022, then grew by 25.0% to $100000.0 in 2023, then grew by 14.0% to $114000.0 in 2024, then jumped by 31.58% to $150000.0 in 2025, then grew by 6.0% to $159000.0 in 2026.
- Per Business Quant, the three latest DMAC Accumulated Depreciation figures stand at $159000.0 (Q1 2026), $150000.0 (Q4 2025), and $139000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 159,000.00 |
| Dec 31, 2025 | 150,000.00 |
| Sep 30, 2025 | 139,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 122,000.00 |
| Dec 31, 2024 | 114,000.00 |
| Sep 30, 2024 | 103,000.00 |
| Jun 30, 2024 | 98,000.00 |
| Mar 31, 2024 | 106,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 89,000.00 |
| Mar 31, 2023 | 83,000.00 |
| Dec 31, 2022 | 80,000.00 |
| Sep 30, 2022 | 73,000.00 |
| Jun 30, 2022 | 67,000.00 |
| Mar 31, 2022 | 62,000.00 |
| Dec 31, 2021 | 67,000.00 |
| Sep 30, 2021 | 60,000.00 |
| Jun 30, 2021 | 54,000.00 |